NCT07226453 2026-03-13
PNOC041
University of California, San Francisco
Phase 2 Recruiting
Clinical Trials
13 trialsNCT07291297 2026-03-05
Metformin Hydrochloride in Combination With Standard of Care Systemic Therapy in Previously Untreated Advanced Unresectable or Metastatic Soft Tissue Sarcoma
Wake Forest University Health Sciences
Phase 2 Recruiting
NCT07387900 2026-02-06
Evaluation of the Chemo-preventive Effect of Combined Topical and Systemic Metformin on Oral Leukoplakia
Cairo University
Phase 2 Recruiting
NCT05929495 2025-07-25
Phase 2, Open-label, Single-arm Study on the Use of Metformin as Adjunctive Therapy in High-grade Glioma
University of Milano Bicocca
Phase 2 Recruiting
NCT06687876 2025-07-10
MEMENTO
Amsterdam UMC, location VUmc
Phase 2 Recruiting
NCT03675893 2025-06-15
RESOLVE: Abemaciclib + Letrozole +/- Metformin, Zotatifin, or Gedatolisib in Endometrial or Low-Grade Serous Ovarian Cancer
Dana-Farber Cancer Institute
Phase 2 Recruiting
NCT06826092 2025-02-13
Metformin for the Treatment of mCRC Patients Undergoing FOLFIRI Plus Target Therapy
Kaohsiung Medical University Chung-Ho Memorial Hospital
Phase 2 Recruiting
NCT04114136 2025-02-10
Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
University of Pittsburgh
Phase 2 Recruiting
NCT04741945 2024-11-22
Repurposing Metformin As a Leukemia-preventive Drug in CCUS and LR-MDS
Rigshospitalet, Denmark
Phase 2 Recruiting
NCT02647827 2024-10-09
PIAII
Karolinska Institutet
Phase 2 Recruiting
NCT06537843 2024-08-05
VenCM
Hospital Municipal São José
Phase 2 Recruiting
NCT03379909 2023-09-21
TROJAN
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase 2 Recruiting
NCT04758000 2023-08-04
Metform-Bone
Istituto Ortopedico Rizzoli
Phase 2 Recruiting